Gene: C1orf53
Official Full Name: chromosome 1 open reading frame 53provided by HGNC
Gene Summary: Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19331 | C1orf53 Knockout cell line (HeLa) | Human | C1orf53 | 1:3~1:6 | Negative | Online Inquiry |
KO19332 | C1orf53 Knockout cell line (HCT 116) | Human | C1orf53 | 1:2~1:4 | Negative | Online Inquiry |
KO19333 | C1orf53 Knockout cell line (HEK293) | Human | C1orf53 | 1:3~1:6 | Negative | Online Inquiry |
KO19334 | C1orf53 Knockout cell line (A549) | Human | C1orf53 | 1:3~1:4 | Negative | Online Inquiry |
C1orf53 Gene Knockout Cell Lines are genetically engineered cell lines designed to facilitate the study of the C1orf53 gene, which has been implicated in various cellular processes, including stress response and signaling pathways. By utilizing CRISPR-Cas9 technology, these cell lines possess a precise knockout of the C1orf53 gene, allowing researchers to dissect its function and understand its role in disease mechanisms, particularly in cancer biology and other pathologies where gene regulation is pivotal.
The primary function of these knockout cell lines is to provide a controlled environment for scientists to observe phenotypic changes associated with the absence of C1orf53. This includes analyzing alterations in cell growth, proliferation, differentiation, and response to external stimuli. The mechanisms by which these observations are made involve advanced genomic editing techniques that ensure the accurate removal of the target gene, thus eliminating confounding factors and enabling clear insights into gene function.
In clinical and research settings, C1orf53 knockout cell lines are invaluable tools, especially for investigating therapeutic targets and validating potential drug candidates. Their ability to mimic pathological conditions makes them vital for understanding the molecular underpinnings of diseases and for screening new treatments, particularly in personalized medicine approaches.
One of the distinct advantages of using C1orf53 Gene Knockout Cell Lines lies in their reliability and specificity compared to traditional methods such as siRNA or small molecule inhibitors, which can produce off-target effects or transient alterations. With our knockout cell lines, researchers benefit from a stable and sustainable system allowing for long-term studies without the variability seen in alternative methods.
Given the increasing importance of genetic studies in developing novel therapies, C1orf53 Gene Knockout Cell Lines stand out as indispensable for researchers, clinicians, and biopharma professionals seeking to advance their understanding of gene function and its implications in health and disease. Our commitment to innovation in biological products ensures that we provide tools that are not only scientifically rigorous but also user-friendly, tailored to meet the evolving needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.